Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Medcalo Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in the development and production of chemical drugs and modernized traditional Chinese medicines (TCM). Headquartered in Chengdu with extensive manufacturing facilities in Shifang, the company produces a diverse range of therapies including anti-infectives, analgesics, and metabolic treatments. Its commercial portfolio features prominent products such as Pazufloxacin Mesylate and Xylitol injections, as well as proprietary TCM formulations like Zhuanggu Zhitong and Dangfeiliganning capsules. Medcalo is recognized for its large-scale GMP-certified production capabilities and recently inaugurated a 295-acre modernized technology base to enhance its intelligent manufacturing and quality control systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Medcalo Pharmaceutical.